Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Broncus Holding Corporation, a medical device company, focuses on the development of interventional pulmonology products in Mainland China, the European Union, the United States, and internationally. The company provides navigation products, such as LungPoint Virtual Bronchoscopic Navigation, a computer-assisted image-based navigation software system; LungPoint Plus, a system that provides real-time navigation within the airways for...
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.
Target Price
The average target price of 2216.HK is 1.5 and suggests 40% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
